Back to top
more

Cardinal Health (CAH)

(Delayed Data from NYSE)

$190.77 USD

190.77
4,080,680

+0.93 (0.49%)

Updated Oct 31, 2025 04:00 PM ET

After-Market: $190.82 +0.05 (0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.93%
2Buy18.16%
3Hold10.10%
4Sell5.63%
5Strong Sell2.84%
S&P50011.45%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 21% (50 out of 243)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Indrajit Bandyopadhyay headshot

4 Resilient Dental Supply Players Positioned to Withstand Tariff Risks

by Indrajit Bandyopadhyay

Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.

Zacks Equity Research

Company News for Oct 31, 2025

by Zacks Equity Research

Companies in The News Are: WDC,LLY,IP,CAH

Zacks Equity Research

CAH Q1 Earnings Beat Estimates, '26 EPS View Up, Stock Gains

by Zacks Equity Research

Cardinal Health delivered a strong Q1 beat and lifted its 2026 EPS outlook, fueled by broad-based growth and rising profits across all business segments.

Zacks Equity Research

Compared to Estimates, Cardinal (CAH) Q1 Earnings: A Look at Key Metrics

by Zacks Equity Research

While the top- and bottom-line numbers for Cardinal (CAH) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Equity Research

Cardinal Health (CAH) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Cardinal (CAH) delivered earnings and revenue surprises of +15.38% and +8.39%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Here's Why Cardinal Health (CAH) is a Strong Growth Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Henry Schein (HSIC) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Cardinal (CAH) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

by Zacks Equity Research

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Cardinal (CAH), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2025.

Zacks Equity Research

Cardinal Health (CAH) Laps the Stock Market: Here's Why

by Zacks Equity Research

In the closing of the recent trading day, Cardinal Health (CAH) stood at $161.89, denoting a +1.72% move from the preceding trading day.

Zacks Equity Research

Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings

by Zacks Equity Research

CAH's Pharmaceutical and Specialty units are expected to have fueled double-digit revenue growth in Q1 FY26 despite tariff and cost headwinds.

Zacks Equity Research

Cardinal Health (CAH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Are Investors Undervaluing Cardinal Health (CAH) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Here's Why Cardinal Health (CAH) is a Strong Value Stock

by Zacks Equity Research

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Moumi Mondal headshot

CVS Expands Its Nationwide Care Network With Rite Aid Acquisition

by Moumi Mondal

CVS Pharmacy completes the Rite Aid deal, adding 63 stores, 626 pharmacies and nine million patients to its national care network.

Zacks Equity Research

Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now

by Zacks Equity Research

WST's growth prospects remain strong, fueled by GLP-1 demand and high-value products, though tariffs and execution risks weigh on margins.

Zacks Equity Research

Cardinal Health (CAH) Stock Slides as Market Rises: Facts to Know Before You Trade

by Zacks Equity Research

The latest trading day saw Cardinal Health (CAH) settling at $154.31, representing a -1.64% change from its previous close.

Zacks Equity Research

Here's Why Cardinal Health (CAH) is a Strong Growth Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

The Launch of Foot and Ankle Trauma Solutions May Boost ZBH Stock

by Zacks Equity Research

Zimmer Biomet expands its foot & ankle trauma lineup with Gorilla Pilon Fusion & Phantom TTC Trauma Nail launches.

Zacks Equity Research

McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio

by Zacks Equity Research

MCK is transforming from a traditional distributor into a specialty-driven healthcare solutions leader, focusing on oncology, biopharma services and automation while preparing to separate its Medical-Surgical unit.

Zacks Equity Research

Should You Continue to Hold Bio-Techne Stock in Your Portfolio?

by Zacks Equity Research

TECH drives growth via acquisitions, international strength and innovation. However, it faces macro pressures and rising competition.

Zacks Equity Research

CAH Expands Distribution Network With Indianapolis Facility

by Zacks Equity Research

Cardinal Health accelerates its multi-year supply chain transformation with a new flagship Indianapolis distribution center, reinforcing automation-driven efficiency while building on recent logistics expansions in Ohio and Texas.

Zacks Equity Research

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Is Cardinal Health (CAH) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Cardinal Health (CAH) Stock Dips While Market Gains: Key Facts

by Zacks Equity Research

The latest trading day saw Cardinal Health (CAH) settling at $154.46, representing a -2.52% change from its previous close.

Zacks Equity Research

Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.